Time
Days to earnings7
Next print2026-10-21
WindowBMO
Fiscal2026-09-30
NYSE · HEALTHCARE · MEDICAL DEVICES
ABT
Abbott Laboratories primary
101.83
Full stocks workspace →+2.15+2.2%
Street
Consensus EPS1.415
Consensus revenue13.0B
EPS high / low1.44 / 1.31 · 9.2% · n=23
Rev / avg1 / — · 1.42 / 1.42
Options
IV front29.8%
Implied move4.7%
Put/call full0.62
Put/call front0.52
Short interest
Short shares13.6M / 19.9M · -31.52%
Days to cover1.46
Avg vol · float9.3M · 1.7B
Short % float0.79%
| Date | DTE | Next | Close | Cons. EPS | IV front % | Implied | Ret 5d | Ret 10d | Ret 20d | Ret 30d | EPS high / low | Dispersion | Analysts | P/C | Peers rpt | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-12 | 7 | 2026-10-21 | 101.83 | 1.415 | 29.8% | 4.7% | +1.7% | +0.8% | -1.2% | -9.5% | 1.44 / 1.31 | 9.2% | 23 | 0.62 | 1 | |
| 2026-10-09 | 8 | 2026-10-21 | 99.68 | 1.42 | 27.3% | 5.0% | +2.2% | -1.6% | -2.2% | -10.7% | 1.44 / 1.41 | 2.1% | 22 | 0.62 | 1 | |
| 2026-10-08 | 9 | 2026-10-21 | 98.51 | 1.42 | 26.9% | 5.1% | +1.9% | -2.5% | -4.7% | -13.7% | 1.44 / 1.41 | 2.1% | 22 | 0.63 | 1 | |
| 2026-10-06 | 11 | 2026-10-21 | 98.19 | 1.42 | 26.9% | 5.4% | -2.7% | -5.3% | -6.9% | -15.8% | 1.44 / 1.41 | 2.1% | 22 | 0.60 | 1 | |
| 2026-10-05 | 12 | 2026-10-21 | 100.13 | 1.42 | 26.9% | 5.6% | -0.8% | -2.8% | -7.6% | -14.2% | 1.44 / 1.41 | 2.1% | 22 | 0.60 | 1 | |
| 2026-10-02 | 13 | 2026-10-21 | 97.53 | 1.42 | 25.4% | 5.8% | -3.7% | -5.0% | -10.4% | -14.6% | 1.44 / 1.41 | 2.1% | 22 | 0.61 | 1 | |
| 2026-10-01 | 14 | 2026-10-21 | 96.69 | 1.42 | 29.3% | 6.9% | -4.3% | -5.4% | -12.5% | -15.5% | 1.44 / 1.41 | 2.1% | 22 | 0.61 | 1 | |
| 2026-09-30 | 15 | 2026-10-21 | 98.84 | 1.42 | 26.4% | 6.3% | -4.5% | -3.4% | -9.3% | -12.3% | 1.44 / 1.41 | 2.1% | 22 | 0.60 | 1 | |
| 2026-09-29 | 16 | 2026-10-21 | 100.96 | 1.42 | 29.3% | 7.2% | -2.6% | -1.0% | -8.5% | -8.5% | 1.44 / 1.41 | 2.1% | 22 | 0.62 | 1 | |
| 2026-09-28 | 17 | 2026-10-21 | 100.98 | 1.42 | 28.3% | 7.1% | -1.9% | -2.0% | -10.2% | -9.2% | 1.44 / 1.41 | 2.1% | 22 | 0.61 | 1 |
Linked names and their last print
| Peer | Name | Score | Last qtr | Last surprise | Reaction | 1-day close | DTE (full) |
|---|---|---|---|---|---|---|---|
| MDT primary | Medtronic PLC | 0.55 | 2027Q1 · 2026-09-01 | +4.3% | +1.5% | 92.06 | 26 · 2026-10-12 |
| SYK primary | Stryker Corporation | 0.51 | 2026Q2 · 2026-07-30 | +6.6% | -5.2% | 325.70 | 13 · 2026-10-12 |
| BSX primary | Boston Scientific Corp | 0.36 | 2026Q2 · 2026-07-29 | +3.6% | -7.4% | 46.04 | 12 · 2026-10-12 |
| JNJ primary | Johnson & Johnson | 0.30 | 2026Q2 · 2026-07-15 | +2.1% | -1.5% | 247.02 | 1 · 2026-10-12 |
| Fiscal qtr | Report date | Window | Actual EPS | Surprise % | Beat | Reaction | 1-day result | Vol ×10d | Post 10d | Review |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2026-07-16 | BMO | 1.31 | +2.3% | Beat | +6.7% | +3.7% | 2.82× | +6.9% | Review |
| 2026Q1 | 2026-04-16 | BMO | 1.15 | 0.0% | — | -4.4% | -1.7% | 2.88× | -4.9% | Review |
| 2025Q4 | 2026-01-22 | BMO | 1.50 | +0.7% | Beat | -10.9% | +1.0% | 4.92× | +0.4% | Review |
| 2025Q3 | 2025-10-15 | BMO | 1.30 | 0.0% | — | -3.9% | +1.1% | 2.44× | -3.9% | Review |
| 2025Q2 | 2025-07-17 | BMO | 1.26 | 0.0% | — | -3.9% | -4.8% | 5.00× | +4.7% | Review |
| 2025Q1 | 2025-04-16 | BMO | 1.09 | +1.9% | Beat | +2.8% | +0.0% | 1.57× | +0.9% | Review |
| 2024Q4 | 2025-01-22 | BMO | 1.34 | 0.0% | — | -2.3% | +3.2% | 2.34× | +12.1% | Review |
| 2024Q3 | 2024-10-16 | BMO | 1.21 | +0.8% | Beat | +1.7% | -0.2% | 1.65× | -2.9% | Review |
| 2024Q2 | 2024-07-18 | BMO | 1.14 | +3.6% | Beat | -2.2% | -2.3% | 2.13× | +10.1% | Review |
| 2024Q1 | 2024-04-17 | BMO | 0.98 | +3.2% | Beat | -1.5% | -1.5% | 2.46× | +0.4% | Review |